Exploring Recent Innovations in Spinal Muscular Atrophy Management
Spinal Muscular Atrophy (SMA) is a genetic disorder that leads to muscle weakness and atrophy, primarily affecting infants and children. Recent innovations in treatment, including therapies like SPINRAZA and ZOLGENSMA, have transformed SMA management, offering hope for improved patient outcomes. Discover the latest advancements and emerging therapies that are reshaping the future of SMA care. […]
3 minute read